{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:dnp_59"},"canonical_url":"https://search.dev.ndltd.org/etd/msu/oai:d.lib.msu.edu:dnp_59","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"Impact of speech amplification devices on quality of life in persons living with Parkinson's disease and hypophonia : a quality improvement project","abstract":"Parkinson's disease (PD) is a progressive, neurodegenerative disorder caused by reduced dopaminergic neurons of the brain that frequently cause speech and voice disturbances (Mohseni et al., 2023). Of the motor and nonmotor symptoms that develop in PD, tremor, speech difficulties, and muscle rigidity are the most common (World Health Organization, 2023). The pathophysiology of PD is not well understood and there is no cure. However, quality of life is immensely impacted. Collectively, the speech disorder of PD is known as hypokinetic dysarthria, occurring in various stages in up to 90% of Persons Living with Parkinson's Disease (PLwPD) (Mohseni et al., 2023). Hypophonia, or reduced speech intensity, is the most prevalent symptom of hypokinetic dysarthria that develops in about 70% of individuals with PD (Adams, 2020). Symptom management by implementing use of a speech amplification device with behavior management and referral to speech pathology, is key in reducing the impact that hypophonia has on individuals with PD and their carers. The goal of the quality improvement project was to use the available literature and personal interviews to determine whether speech amplification devices could be implemented, effectively utilized, and improve quality of life among this population and those of the population who may face social and economic challenges.","abstract_html":"Parkinson's disease (PD) is a progressive, neurodegenerative disorder caused by reduced dopaminergic neurons of the brain that frequently cause speech and voice disturbances (Mohseni et al., 2023). Of the motor and nonmotor symptoms that develop in PD, tremor, speech difficulties, and muscle rigidity are the most common (World Health Organization, 2023). The pathophysiology of PD is not well understood and there is no cure. However, quality of life is immensely impacted. Collectively, the speech disorder of PD is known as hypokinetic dysarthria, occurring in various stages in up to 90% of Persons Living with Parkinson's Disease (PLwPD) (Mohseni et al., 2023). Hypophonia, or reduced speech intensity, is the most prevalent symptom of hypokinetic dysarthria that develops in about 70% of individuals with PD (Adams, 2020). Symptom management by implementing use of a speech amplification device with behavior management and referral to speech pathology, is key in reducing the impact that hypophonia has on individuals with PD and their carers. The goal of the quality improvement project was to use the available literature and personal interviews to determine whether speech amplification devices could be implemented, effectively utilized, and improve quality of life among this population and those of the population who may face social and economic challenges.","abstract_has_math":false,"creators":["Buhr, Monica","McDaniel, Cailin"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Keilman, Linda J."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024","date_published":"2024","updated_at":"2026-07-24T03:16:39Z","subjects":["Quality of life","Speech disorders--Patients--Means of communication","Speech therapy--Instruments"],"languages":["English"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["dnp:59","oclc:1458458344","local:R_6im84DnHe407MMf"],"render_values":[{"text":"dnp:59","href":null,"code":true},{"text":"oclc:1458458344","href":null,"code":true},{"text":"local:R_6im84DnHe407MMf","href":null,"code":true}]}]},"links":{"outbound_url":"https://doi.org/doi:10.25335/btjb-9h08","outbound_label":"DOI","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Keilman, Linda J."]},{"key":"dc:creator","label":"Author","values":["Buhr, Monica","McDaniel, Cailin"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2024"]},{"key":"dc:relation","label":"Dc Relation","values":["Doctor of Nursing Practice Projects"]},{"key":"dc:type","label":"Dc Type","values":["Text","Theses"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Quality of life","Speech disorders--Patients--Means of communication","Speech therapy--Instruments"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["dnp:59","oclc:1458458344","local:R_6im84DnHe407MMf","https://doi.org/doi:10.25335/btjb-9h08"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Parkinson's disease (PD) is a progressive, neurodegenerative disorder caused by reduced dopaminergic neurons of the brain that frequently cause speech and voice disturbances (Mohseni et al., 2023). Of the motor and nonmotor symptoms that develop in PD, tremor, speech difficulties, and muscle rigidity are the most common (World Health Organization, 2023). The pathophysiology of PD is not well understood and there is no cure. However, quality of life is immensely impacted. Collectively, the speech disorder of PD is known as hypokinetic dysarthria, occurring in various stages in up to 90% of Persons Living with Parkinson's Disease (PLwPD) (Mohseni et al., 2023). Hypophonia, or reduced speech intensity, is the most prevalent symptom of hypokinetic dysarthria that develops in about 70% of individuals with PD (Adams, 2020). Symptom management by implementing use of a speech amplification device with behavior management and referral to speech pathology, is key in reducing the impact that hypophonia has on individuals with PD and their carers. The goal of the quality improvement project was to use the available literature and personal interviews to determine whether speech amplification devices could be implemented, effectively utilized, and improve quality of life among this population and those of the population who may face social and economic challenges.","Thesis (D.N.P.)--Michigan State University. Adult gerontology primary nurse practitioner, 2024","Includes bibliographical references (pages 34-39)"]},{"key":"dc:format","label":"Dc Format","values":["52 pages","application/pdf"]},{"key":"dc:title","label":"Title","values":["Impact of speech amplification devices on quality of life in persons living with Parkinson's disease and hypophonia : a quality improvement project"]}]}],"canonical_facts":{"dc:contributor":["Keilman, Linda J."],"dc:creator":["Buhr, Monica","McDaniel, Cailin"],"dc:date":["2024"],"dc:description":["Parkinson's disease (PD) is a progressive, neurodegenerative disorder caused by reduced dopaminergic neurons of the brain that frequently cause speech and voice disturbances (Mohseni et al., 2023). Of the motor and nonmotor symptoms that develop in PD, tremor, speech difficulties, and muscle rigidity are the most common (World Health Organization, 2023). The pathophysiology of PD is not well understood and there is no cure. However, quality of life is immensely impacted. Collectively, the speech disorder of PD is known as hypokinetic dysarthria, occurring in various stages in up to 90% of Persons Living with Parkinson's Disease (PLwPD) (Mohseni et al., 2023). Hypophonia, or reduced speech intensity, is the most prevalent symptom of hypokinetic dysarthria that develops in about 70% of individuals with PD (Adams, 2020). Symptom management by implementing use of a speech amplification device with behavior management and referral to speech pathology, is key in reducing the impact that hypophonia has on individuals with PD and their carers. The goal of the quality improvement project was to use the available literature and personal interviews to determine whether speech amplification devices could be implemented, effectively utilized, and improve quality of life among this population and those of the population who may face social and economic challenges.","Thesis (D.N.P.)--Michigan State University. Adult gerontology primary nurse practitioner, 2024","Includes bibliographical references (pages 34-39)"],"dc:format":["52 pages","application/pdf"],"dc:identifier":["dnp:59","oclc:1458458344","local:R_6im84DnHe407MMf","https://doi.org/doi:10.25335/btjb-9h08"],"dc:language":["English"],"dc:relation":["Doctor of Nursing Practice Projects"],"dc:rights":["In Copyright"],"dc:subject":["Quality of life","Speech disorders--Patients--Means of communication","Speech therapy--Instruments"],"dc:title":["Impact of speech amplification devices on quality of life in persons living with Parkinson's disease and hypophonia : a quality improvement project"],"dc:type":["Text","Theses"]},"updated_at":"2026-07-24T03:16:39Z"}